Unraveling the complexity of oncology trials

Exploring the role of Interactive Response Technology and Electronic Clinical Outcome Assessment in enhancing oncology clinical research 

Oncology clinical trials are notably challenging, with long durations and low success rates. In 2022, only 3.5% of these trials were successful, and the process is complicated by recruitment difficulties, high mortality rates, and complex treatments. This whitepaper explores how eClinical technologies, particularly Interactive Response Technology (IRT) and Electronic Clinical Outcome Assessment (eCOA), are helping to address these challenges. IRT systems offer flexibility in managing adaptive treatments, optimizing drug supply, and streamlining operational tasks, while eCOA creates efficient collection of patient-reported outcomes, vital for assessing quality of life and treatment efficacy. The paper presents case studies from Suvoda, showcasing how eClinical solutions have successfully managed complex trials across various oncology indications. The integration of these technologies is crucial for future oncology trials, offering patient-centric solutions, operational efficiency, and agility in research. 

What you will learn: 

• Managing complexity: Learn how IRT systems handle multiple disease types, adaptive treatment strategies, and evolving cohorts in oncology trials.

• Patient-centric data collection: Understand the importance of eCOA in capturing patient-reported outcomes to evaluate treatment efficacy and patient quality of life.

• Operational efficiency: Discover how IRT and eCOA technologies streamline processes, reduce operational burdens, and enhance trial execution.

• Case study insights: Gain insights from real-world oncology trial examples showcasing the effectiveness of IRT in overcoming trial complexities.